Feng-Juan Yan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Feng-Juan Yan

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Nature Communications|November 25, 2025

The E3 ligase tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation in male miceFeng-Juan Yan, Han Ding, Ning Zhang, et al.

Hepatology (Baltimore, Md.)|December 17, 2016

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitisFeng-Juan Yan, Xiao-Jing Zhang, Wen-Xin Wang, et al.

Hepatology (Baltimore, Md.)|October 28, 2017

Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liverSiyuan Wang, Zhen-Zhen Yan, Xia Yang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Nature Communications|November 25, 2025

The E3 ligase tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation in male miceFeng-Juan Yan, Han Ding, Ning Zhang, et al.

Hepatology (Baltimore, Md.)|December 17, 2016

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitisFeng-Juan Yan, Xiao-Jing Zhang, Wen-Xin Wang, et al.

Hepatology (Baltimore, Md.)|October 28, 2017

Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liverSiyuan Wang, Zhen-Zhen Yan, Xia Yang, et al.

Pageof 2